Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: Armstrong Ventures Raises GBP2.3 Million, Changes Focus (ALLISS)

Mon, 22nd Jun 2015 10:45

LONDON (Alliance News) - Armstrong Ventures PLC on Monday said it has raised GBP2 million after expenses by issuing new shares, as it decided to switch its focus to investing in the media, technology and healthcare sectors instead of the resources sector.

In a statement, the investing company said it has raised GBP2.3 million before expenses by issuing 19.40 billion new shares to new and existing investors at a placing price of 0.012 pence per share.

Sean Nicolson, executive director of drug discovery company e-Therapeutics PLC, has been appointed to the board along with former KPMG partner Peter Read.

The decision to invest in the media, technology and healthcare sectors came after Chairman Haresh Kanabar said earlier on Monday that the general market conditions have been difficult for small AIM-listed companies focused on the resources and energy sectors.

"The board has looked at a number of possible acquisitions for the company, but none were suitable to be tabled for the consideration of the shareholders. A greater proportion of the possible transactions that we looked at required funds to be raised as part of the acquisition, and there has not been market support for such fund raisings in our focused sector. The outlook for market conditions in the resources and energy sectors continues to be challenging, and we do not see any improvement in the near term horizon," Kanabar said earlier on Monday.

Armstrong Ventures said it was "hopeful" about the future, despite operating against tough conditions, which it doesn't see improving in the near term.

"As I have indicated before, the operating environment for small investing companies such as ours continues to be challenging, but we remain hopeful for the future," Chairman Haresh Kanabar had said.

The investing company recorded a loss before and after tax of GBP184,079 in 2014, compared with GBP262,406 in 2013.

Shareholder approval is required for the new investing policy.

Armstrong Ventures shares were down 25% on Monday morning at 0.015p.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 Jul 2021 13:47

E-therapeutics meets 'key milestone' in Galapagos collaboration

(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.

Read more
9 Jun 2021 16:08

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
2 Jun 2021 16:02

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

Read more
2 Jun 2021 09:42

E-therapeutics brings in Alison Gallafent as head of IP

(Sharecast News) - Drug discovery company e-therapeutics announced the appointment of Alison Gallafent as its head of intellectual property on Wednesday.

Read more
14 May 2021 14:20

E-therapeutics raises £22.5m to expand capabilities and pipeline

(Sharecast News) - E-therapeutics has completed a placing, subscription and retail offer via PrimaryBid, it announced on Friday, conditionally raising gross proceeds of £22.5m to help expand its drug discovery and development capabilities and asset pipeline.

Read more
14 May 2021 10:23

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

Read more
14 May 2021 09:48

e-Therapeutics raises GBP23 million to expand capability and pipeline

e-Therapeutics raises GBP23 million to expand capability and pipeline

Read more
13 May 2021 17:52

IN BRIEF: e-Therapeutics to raise GBP20 million to expand capability

IN BRIEF: e-Therapeutics to raise GBP20 million to expand capability

Read more
13 May 2021 16:40

TRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity

TRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity

Read more
13 May 2021 10:29

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

Read more
6 May 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
23 Apr 2021 11:31

AIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale

AIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale

Read more
23 Apr 2021 11:29

e-Therapeutics gets two payments from Galapagos under collaboration

e-Therapeutics gets two payments from Galapagos under collaboration

Read more
23 Apr 2021 10:18

E-therapeutics to receive two milestone payments from Galapagos

(Sharecast News) - E-therapeutics has met two key milestones in its collaboration with small-molecule medicines specialist Galapagos, it announced on Friday.

Read more
29 Mar 2021 15:13

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.